$25M sweet spot round size
Most of their 12 investments are in rounds between $13M and $35M
2010
- raised $80M on March 1, 2021
Investors: Point72 Asset Management, Vivo Capital, RA Capital Management, L.P., Surveyor Capital, Commodore Capital, LP, Logos Global Management, LP, SNBL USA and Aspire Capital Partners, LLC
Undisclosed raised $90M on December 11, 2020
Investors: Ikarian Capital LLC, Suvretta Capital Management LLC, Perceptive Advisors, RA Capital Management, L.P. and Aspire Capital Partners, LLC
Mereo BioPharma raised $70M on June 4, 2020
Investors: Tavistock Group, Commodore Capital, LP, OrbiMed Advisors, Samsara BioCapital, Vivo Capital, Pontifax Venture Capital, Surveyor Capital and Aspire Capital Partners, LLC
Novan, Inc. raised $25M on September 6, 2019
Investors: Aspire Capital Partners, LLC
Titan Medical Inc. raised $35M on August 30, 2019
Investors: Aspire Capital Partners, LLC
Viking Therapeutics, Inc. raised $13M on August 25, 2016
Investors: Aspire Capital Partners, LLC
Ritter Pharmaceuticals raised $10M on December 21, 2015
Investors: Aspire Capital Partners, LLC
Atossa Genetics, Inc. raised $25M on May 28, 2015
Investors: Aspire Capital Partners, LLC
Sophiris Bio Inc. raised $2M on May 17, 2014
Investors: Aspire Capital Partners, LLC
- raised $20M on August 20, 2012
Investors: Aspire Capital Partners, LLC